ARCHIVES

In Brief: Megastrol Acetate Still Under FDA Review; Mays Hired For NCI’s Technology Office

This article is from The Cancer Letter archive.

Vol. 16 No. 29 | July 20, 1990

Download PDF Visit The Full Archive

Related Articles

NCI To Slow New Center Development To Assure Funding For Existing Commitments, King Says

February 14, 1975

Guest Editorial: Guideline Promises to End Twenty-Year War Over Mass Screening for Prostate Cancer

May 24, 2013

PET Tracer Drug Approved, Developed At Weill Cornell

September 24, 2004

Cytyc Buys Pro-Duct Health, Ductal Lavage Device Maker. TAP To Pay $875 Million To Settle Federal Civil Suit.

October 26, 2001

DCT Board Okays Recompetition of Drug Discovery Groups

October 22, 1993

Trading In Stock Of U.S. Bioscience Halted, Newsletter Report Cited

October 9, 1992